UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improved curve fits to summary survival data: application to economic evaluation of health technologies

BMC medical research methodology, 2011-10, Vol.11 (1), p.139-139, Article 139

2011

Volltextzugriff (PDF)

A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome

Health technology assessment (Winchester, England), 2014-09, Vol.18 (58), p.1-406

2014

Volltextzugriff (PDF)

Historical Lifetimes of Drugs in England: Application to Value of Information and Cost-Effectiveness Analyses

Value in health, 2010-12, Vol.13 (8), p.885-892

Hoyle, Martin, PhD

2010

Volltextzugriff (PDF)

A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients

BMC cancer, 2015-04, Vol.15 (1), p.313-313, Article 313

2015

Volltextzugriff (PDF)

Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysis

Health technology assessment (Winchester, England), 2018-09, Vol.22 (49), p.1-326

2018

Volltextzugriff (PDF)

Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model

Health technology assessment (Winchester, England), 2016-08, Vol.20 (62), p.1-594

2016

Volltextzugriff (PDF)

Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation

Health technology assessment (Winchester, England), 2021-02, Vol.25 (8), p.1-248

2021

Volltextzugriff (PDF)

The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation

Health technology assessment (Winchester, England), 2017-06, Vol.21 (38), p.1-294

2017

Volltextzugriff (PDF)

Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation

Health technology assessment (Winchester, England), 2019-03, Vol.23 (13), p.1-226

2019

Volltextzugriff (PDF)

Effect of pollinator abundance on self-fertilization and gene flow: Application to GM canola

Ecological applications, 2007-10, Vol.17 (7), p.2123-2135

2007

Volltextzugriff (PDF)

Azacitidine for Treating Acute Myeloid Leukaemia with More Than 30 % Bone Marrow Blasts: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal

PharmacoEconomics, 2017-03, Vol.35 (3), p.363-373

2017

Volltextzugriff (PDF)

The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model

Health technology assessment (Winchester, England), 2016-02, Vol.20 (13), p.1-588

2016

Volltextzugriff (PDF)

Cost-Effectiveness of Cetuximab, Cetuximab Plus Irinotecan, and Panitumumab for Third and Further Lines of Treatment for KRAS Wild-Type Patients with Metastatic Colorectal Cancer

Value in health, 2013-03, Vol.16 (2), p.288-296

2013

Volltextzugriff (PDF)

Cost-Effectiveness of Temsirolimus for First Line Treatment of Advanced Renal Cell Carcinoma

Value in health, 2010, Vol.13 (1), p.61-68

2010

Volltextzugriff (PDF)

Complete Cytogenetic Response and Major Molecular Response as Surrogate Outcomes for Overall Survival in First-Line Treatment of Chronic Myelogenous Leukemia: A Case Study for Technology Appraisal on the Basis of Surrogate Outcomes Evidence

Value in health, 2013-09, Vol.16 (6), p.1081-1090

2013

Volltextzugriff (PDF)

Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia

Value in health, 2011-12, Vol.14 (8), p.1057-1067

2011

Volltextzugriff (PDF)

Histopathologically Validated Diagnostic Accuracy of PSMA-PET/CT in the Primary and Secondary Staging of Prostate Cancer and the Impact of PSMA-PET/CT on Clinical Management: A Systematic Review and Meta-analysis

Seminars in nuclear medicine, 2023-09, Vol.53 (5), p.706-718

2023

Volltextzugriff (PDF)

Accounting for the Drug Life Cycle and Future Drug Prices in Cost-Effectiveness Analysis

PharmacoEconomics, 2011, Vol.29 (1), p.1-15

Hoyle, Martin

2011

Volltextzugriff (PDF)

Cost-Effectiveness of Sorafenib for Second-Line Treatment of Advanced Renal Cell Carcinoma

Value in health, 2010, Vol.13 (1), p.55-60

2010

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia

PharmacoEconomics, 2022-08, Vol.40 (8), p.807-821

2022

Volltextzugriff (PDF)

Bring Out Your Dead: A Review of the Cost Minimisation Approach in Health Technology Assessment Submissions to the Australian Pharmaceutical Benefits Advisory Committee

PharmacoEconomics, 2024-11, Vol.42 (11), p.1287-1300

2024

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen for the Primary Staging of Prostate Cancer in Australia

PharmacoEconomics, 2022-08, Vol.40 (8), p.807

2022

Volltextzugriff (PDF)

Whose Costs and Benefits? Why Economic Evaluations Should Simulate Both Prevalent and All Future Incident Patient Cohorts

Medical decision making, 2010-07, Vol.30 (4), p.426-437

2010

Volltextzugriff (PDF)

Microcosting Study of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Prostate Cancer

Value in health regional issues, 2022-11, Vol.32, p.17-22

2022

Volltextzugriff (PDF)

Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model

Age and ageing, 2013-01, Vol.42 (1), p.14-20

2013

Volltextzugriff (PDF)

1 – 25 von 217

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(187)
Mit Volltextzugriff
(185)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(213)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Improved curve fits to summary survival data: application to economic evaluation of health technologies

A systematic review and economic evaluation of diagnostic strategies for Lynch syndrome

Historical Lifetimes of Drugs in England: Application to Value of Information and Cost-Effectiveness Analyses

A model-based assessment of the cost-utility of strategies to identify Lynch syndrome in early-onset colorectal cancer patients

Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysis

Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model

Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation

The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation

Three biomarker tests to help diagnose preterm labour: a systematic review and economic evaluation

Effect of pollinator abundance on self-fertilization and gene flow: Application to GM canola

Azacitidine for Treating Acute Myeloid Leukaemia with More Than 30 % Bone Marrow Blasts: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal

The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model

Cost-Effectiveness of Cetuximab, Cetuximab Plus Irinotecan, and Panitumumab for Third and Further Lines of Treatment for KRAS Wild-Type Patients with Metastatic Colorectal Cancer

Cost-Effectiveness of Temsirolimus for First Line Treatment of Advanced Renal Cell Carcinoma

Complete Cytogenetic Response and Major Molecular Response as Surrogate Outcomes for Overall Survival in First-Line Treatment of Chronic Myelogenous Leukemia: A Case Study for Technology Appraisal on the Basis of Surrogate Outcomes Evidence

Cost-Effectiveness of Dasatinib and Nilotinib for Imatinib-Resistant or -Intolerant Chronic Phase Chronic Myeloid Leukemia

Histopathologically Validated Diagnostic Accuracy of PSMA-PET/CT in the Primary and Secondary Staging of Prostate Cancer and the Impact of PSMA-PET/CT on Clinical Management: A Systematic Review and Meta-analysis

Accounting for the Drug Life Cycle and Future Drug Prices in Cost-Effectiveness Analysis

Cost-Effectiveness of Sorafenib for Second-Line Treatment of Advanced Renal Cell Carcinoma

Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia

Bring Out Your Dead: A Review of the Cost Minimisation Approach in Health Technology Assessment Submissions to the Australian Pharmaceutical Benefits Advisory Committee

Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen for the Primary Staging of Prostate Cancer in Australia

Whose Costs and Benefits? Why Economic Evaluations Should Simulate Both Prevalent and All Future Incident Patient Cohorts

Microcosting Study of Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Prostate Cancer

Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model

Suchergebnisse filtern